Cargando…
1110. Why has Utilization of Novel Gram-negative Antibiotics been Sluggish in U.S. Hospitals? A Retrospective Cohort Study to Inform Future Antibiotic Development and Market Entry Rewards
BACKGROUND: Sluggish uptake of novel gram-negative antibiotics has jeopardized their future development and supply potentially risking patient lives. Understanding underutilization patterns might better inform unmet needs and market entry rewards. We studied patterns and drivers of use of recently U...
Autores principales: | Strich, Jeffrey R, Ullah Mishuk, Ahmed, Lawandi, Alexander, Diao, Guoqing, Warner, Sarah, Li, Willy, Demirkale, Cumhur Y, Mancera, Alex, Walker, Morgan, Yek, Christina, Neupane, Maniraj, De Jonge, Nathaniel, Kadri, Sameer S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10679413/ http://dx.doi.org/10.1093/ofid/ofad500.083 |
Ejemplares similares
-
272. Do Empiric Antibiotics Improve Outcomes in Clinically Stable Patients Admitted with COVID-19 Pneumonia? Retrospective Cohort Study of 221 U.S. Hospitals, March 1st, 2020-December 31st, 2020
por: Lawandi, Alexander, et al.
Publicado: (2022) -
2251. Estimating the Need for Novel Gram-Negative Active Antibiotics in US Hospitals
por: Strich, Jeffrey R, et al.
Publicado: (2019) -
Needs assessment for novel Gram-negative antibiotics in US hospitals: a retrospective cohort study
por: Strich, Jeffrey R, et al.
Publicado: (2020) -
Real-World Inpatient Use of Medications Repurposed for Coronavirus Disease 2019 in United States Hospitals, March–May 2020
por: Kadri, Sameer S, et al.
Publicado: (2020) -
Misclassification bias in estimating clinical severity of SARS-CoV-2 variants
por: Yek, Christina, et al.
Publicado: (2022)